These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2399814)

  • 1. Urinary phenylacetic acid in panic disorder with and without depression.
    Sabelli HC; Javaid JI; Fawcett J; Kravitz HM; Wynn P
    Acta Psychiatr Scand; 1990 Jul; 82(1):14-6. PubMed ID: 2399814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary phenylacetic acid excretion in depressive patients.
    González-Sastre F; Mora J; Guillamat R; Queraltó JM; Alvarez E; Udina C; Massana J
    Acta Psychiatr Scand; 1988 Aug; 78(2):208-10. PubMed ID: 3223321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder.
    Kathol RG; Anton R; Noyes R; Gehris T
    Biol Psychiatry; 1989 Apr; 25(7):873-8. PubMed ID: 2720002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary phenyl acetate: a diagnostic test for depression?
    Sabelli HC; Fawcett J; Gusovsky F; Javaid J; Edwards J; Jeffriess H
    Science; 1983 Jun; 220(4602):1187-8. PubMed ID: 6857245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet imipramine binding in patients with panic disorder and major familial depression.
    Pecknold JC; Chang H; Fleury D; Koszychi D; Quirion R; Nair NP; Suranyi-Cadotte BE
    J Psychiatr Res; 1987; 21(3):319-26. PubMed ID: 3681766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylethylamine excretion in depression.
    DeLisi LE; Murphy DL; Karoum F; Mueller E; Targum S; Wyatt RJ
    Psychiatry Res; 1984 Nov; 13(3):193-201. PubMed ID: 6597458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors.
    Grunhaus LJ; Cameron O; Pande AC; Haskett RF; Hollingsworth PJ; Smith CB
    Acta Psychiatr Scand; 1990 Mar; 81(3):216-9. PubMed ID: 2160772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate infusions in major depression without panic attacks.
    Cowley DS; Dager SR; Dunner DL
    J Psychiatr Res; 1987; 21(3):243-8. PubMed ID: 3681759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary phenylacetate and response to methylphenidate.
    Baxter LR; Kelly RC; Peter JB; Liston EH; Touserkani S
    J Psychiatr Res; 1988; 22(2):131-9. PubMed ID: 3404481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of anxiogenic vulnerability in panic disorder.
    Targum SD
    Psychiatry Res; 1990 Feb; 31(2):215-6. PubMed ID: 2326400
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
    Karoum F; Potkin S; Chuang LW; Murphy DL; Liebowitz MR; Wyatt RJ
    Biol Psychiatry; 1984 Feb; 19(2):165-78. PubMed ID: 6713036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary catecholamines and mitral valve prolapse in panic-anxiety patients.
    Nesse RM; Cameron OG; Buda AJ; McCann DS; Curtis GC; Huber-Smith MJ
    Psychiatry Res; 1985 Jan; 14(1):67-75. PubMed ID: 3857649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interface of panic and depression: clinical and sleep EEG correlates.
    Dubé S; Jones DA; Bell J; Davies A; Ross E; Sitaram N
    Psychiatry Res; 1986 Oct; 19(2):119-33. PubMed ID: 3786604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone response to clonidine in panic disorder patients.
    Schittecatte M; Charles G; Depauw Y; Mesters P; Wilmotte J
    Psychiatry Res; 1988 Feb; 23(2):147-51. PubMed ID: 3363023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major depression in patients with agoraphobia and panic disorder.
    Breier A; Charney DS; Heninger GR
    Arch Gen Psychiatry; 1984 Dec; 41(12):1129-35. PubMed ID: 6508503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
    Garvey M; Noyes R; Cook B; Tollefson G
    Psychiatry Res; 1989 Oct; 30(1):53-61. PubMed ID: 2594871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements.
    Sabelli HC; Fawcett J; Gusovsky F; Javaid JI; Wynn P; Edwards J; Jeffriess H; Kravitz H
    J Clin Psychiatry; 1986 Feb; 47(2):66-70. PubMed ID: 3944066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dexamethasone suppression test in panic disorder.
    Judd FK; Norman TR; Burrows GD; McIntyre IM
    Pharmacopsychiatry; 1987 May; 20(3):99-101. PubMed ID: 3602097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social phobic symptoms in patients with panic disorder: practical and theoretical implications.
    Stein MB; Shea CA; Uhde TW
    Am J Psychiatry; 1989 Feb; 146(2):235-8. PubMed ID: 2912265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panic disorder and major depression. Increased risk of depression, alcoholism, panic, and phobic disorders in families of depressed probands with panic disorder.
    Leckman JF; Weissman MM; Merikangas KR; Pauls DL; Prusoff BA
    Arch Gen Psychiatry; 1983 Oct; 40(10):1055-60. PubMed ID: 6625853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.